MPO and pancreatic neoplasm: Subjects carrying the G-463A MPO polymorphism have higher levels of total and low-density lipoprotein-associated cholesterol, and elevated risk for coronary artery disease [53], MPO-ANCA vasculitis [54], lung [55,56], and pancreas cancer [57].